Gregory Downey - 14 Oct 2022 Form 4/A - Amendment Insider Report for Lexaria Bioscience Corp. (LEXX)

Role: Chief Financial Officer
Signature: /Gregory Downey/
Issuer symbol: LEXX
Transactions as of: 14 Oct 2022
Net transactions value: +$253
Form type: 4/A - Amendment
Filing time: 18 Oct 2022, 18:31:43 UTC
Date Of Original Report: 18 Oct 2022
Previous filing: 29 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LEXX	common shares	Purchase	$253	+121	+6.6%	$2.09	1,954	14 Oct 2022	Direct	F1
holding	LEXX	common shares						1,833	14 Oct 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	LEXX	Stock Options						4,000	14 Oct 2022	Common Shares	4,000	$5.04	Direct
holding	LEXX	Stock Options						8,000	14 Oct 2022	Common Shares	4,000	$5.04	Direct
holding	LEXX	Stock Options						12,000	14 Oct 2022	Common Shares	4,000	$5.04	Direct
holding	LEXX	Stock Options						17,000	14 Oct 2022	Common Shares	5,000	$5.31	Direct
holding	LEXX	Stock Options						25,000	14 Oct 2022	Common Shares	8,000	$7.08	Direct
holding	LEXX	Stock Options						35,000	14 Oct 2022	Common Shares	10,000	$6.23	Direct
holding	LEXX	Stock Options						46,000	14 Oct 2022	Common Shares	11,000	$2.91	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 4A is being filed to correct the transaction code for the open market purchase made by Mr. Downey as originally notated as a grant or award in the Form 4 filed on October 18, 2022.